Potential clinical implications of BRAF mutations in histiocytic proliferations.
Bubolz AM, Weissinger SE, Stenzinger A, Arndt A, Steinestel K, Brüderlein S, Cario H, Lubatschofski A, Welke C, Anagnostopoulos I, Barth TF, Beer AJ, Möller P, Gottstein M, Viardot A, Lennerz JK.
Bubolz AM, et al. Among authors: weissinger se.
Oncotarget. 2014 Jun 30;5(12):4060-70. doi: 10.18632/oncotarget.2061.
Oncotarget. 2014.
PMID: 24938183
Free PMC article.